This is a community-generated profile. If you would like to claim it, please .
Ardelyx
Develops oral therapeutics for mineral metabolism and metabolic disorders201-500 EmployeesActively Hiring
Ardelyx Funding
$35M
22 rounds
Ardelyx is active in the following markets / industries: biotechnology. The company has secured funding across 2 rounds, totaling in an amount of $35M. Their most recent funding was raised on August 31, 2011.
Funding Rounds
B
$30000000Series BAug 2011
U
$5000000Investors of Ardelyx
Amgen Ventures
Foresite Capital
Broadfin Capital
RA Capital Management, L.P.
Invests in life-sciences and drug development companies
Rock Springs Capital
Dafna Capital Management
EcoR1 Capital
Quadrille Capital
Perceptive Advisors